South Wales, Oct. 6 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "RYVIZLA" on Sept. 16. The details about the trademark application no. UK00004446124 published in the journal no. 2026/040 (Oct. 2).
With Fox Williams LLP as representative, Viridian Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004446124
Disclaimer: Curated by HT Syndication.
